Published on:
March 6, 2026
If you have been exploring your fertility options or simply want a clearer picture of your reproductive health, you may have come across the term AMH blood test. Anti-Müllerian Hormone (AMH) testing has become one of the most commonly requested fertility assessments, offering a snapshot of your ovarian reserve — the estimated number of eggs remaining in your ovaries. But what does your AMH result actually tell you, and just as importantly, what does it not tell you? This guide explains everything you need to know about AMH testing, how to interpret your results, and the practical next steps you can take.
Anti-Müllerian Hormone is a protein produced by the granulosa cells in your ovarian follicles — the tiny fluid-filled sacs that each contain a developing egg. From puberty onwards, your ovaries produce AMH, and the level of this hormone in your blood is thought to reflect the size of your remaining egg supply. In simple terms, the more developing follicles you have, the higher your AMH level is likely to be.
AMH is produced by small antral and pre-antral follicles, which represent the pool of eggs that could potentially be recruited for ovulation in the coming months and years. Unlike other hormones involved in the menstrual cycle — such as follicle-stimulating hormone (FSH) or oestradiol — AMH levels remain relatively stable throughout your cycle, making it a convenient and reliable marker to measure at any point.
It is important to understand that AMH gives an indication of egg quantity, not egg quality. Egg quality is primarily influenced by age and is a separate but equally critical factor in fertility. We will explore this distinction in more detail later in this article.
The AMH blood test is refreshingly straightforward. It involves a simple blood draw from your arm, much like any routine blood test. One of the key advantages of AMH testing is that it can be performed on any day of your menstrual cycle, unlike FSH testing, which typically needs to be done on day two or three. You do not need to fast before the test, and there is no special preparation required.
Once your blood sample is collected, it is sent to a laboratory for analysis. Results are usually available within a few days, and the AMH concentration is reported in either nanograms per millilitre (ng/mL) or picomoles per litre (pmol/L), depending on the laboratory. It is worth noting that these two units require different reference ranges, so always check which unit your result uses before comparing it to published guidelines.
Your clinician may recommend an AMH test alongside an ultrasound assessment, such as an antral follicle count (AFC), which provides a visual estimate of the small follicles visible on the ovaries. Together, these two tests give the most comprehensive picture of ovarian reserve currently available in clinical practice.
AMH levels vary significantly between individuals and naturally decline with age. As a general guide, the following ranges are commonly referenced for women of reproductive age (measured in ng/mL):
These ranges are approximate, and interpretation should always consider your age. An AMH of 1.5 ng/mL may be entirely expected for a woman in her late thirties but might warrant further investigation in a 25-year-old. Context is everything, which is why discussing your results with a qualified healthcare professional is essential.
A low AMH result indicates that your ovarian reserve — the number of eggs available for potential fertilisation — is lower than the average for your age group. This can understandably feel alarming, but it is crucial to put this result into perspective. A low AMH does not mean you cannot conceive. Research from the American Society for Reproductive Medicine has found that women with low AMH levels who have no other known fertility issues can have similar cumulative pregnancy rates to women with normal AMH levels when trying to conceive naturally.
However, a low AMH result does have significant implications if you are considering assisted reproduction. In the context of IVF, a lower AMH typically predicts a reduced response to ovarian stimulation, meaning fewer eggs may be retrieved during a cycle. This does not necessarily determine the outcome — it takes only one good-quality egg to achieve a successful pregnancy — but it does influence treatment planning and the approach your fertility specialist may recommend.
Low AMH can also be associated with early perimenopause, premature ovarian insufficiency, or previous ovarian surgery. If your result is unexpectedly low, your doctor will likely explore these possibilities and may order additional tests to build a fuller clinical picture.
A higher-than-expected AMH level often indicates a larger pool of developing follicles. Whilst this might sound like a positive finding for fertility, very high levels — typically above 3.5 to 5.0 ng/mL — can be associated with polycystic ovary syndrome (PCOS). PCOS is a common hormonal condition in which the ovaries contain many small follicles that produce elevated levels of AMH.
In the context of IVF, women with high AMH levels are at greater risk of ovarian hyperstimulation syndrome (OHSS), a condition where the ovaries over-respond to fertility medication. Knowing your AMH level in advance allows your fertility team to adjust medication dosages to minimise this risk, making the treatment safer and more effective.
This is perhaps the most important section of this entire article. The AMH blood test is a powerful clinical tool, but it is frequently misunderstood, and that misunderstanding can cause significant and often unnecessary anxiety.
AMH provides a reliable estimate of your ovarian reserve — the approximate number of eggs remaining. It is particularly valuable for:
AMH does not measure egg quality, which is predominantly determined by age. It does not predict your ability to conceive naturally with any meaningful accuracy. A landmark study cited by the American Society for Reproductive Medicine, known as the Time to Conceive study, followed 750 women aged 30 to 44 and found that those with low AMH had comparable natural conception rates to those with normal levels, provided they had no other fertility issues.
Put simply, your AMH result is not a fertility verdict. A woman with a low AMH may conceive naturally without difficulty, whilst a woman with a high AMH may face other challenges such as ovulatory disorders or tubal factors. Fertility is multifactorial, and no single blood test can capture its full complexity. If you have concerns about your ability to conceive, a thorough evaluation — including partner assessment, tubal patency testing, and a review of your overall health — is far more informative than AMH alone. Our infertility services can help guide you through this comprehensive assessment.
Where AMH testing truly excels is in the planning and optimisation of fertility treatments, particularly IVF and egg freezing. Your AMH level helps your fertility specialist predict how your ovaries are likely to respond to stimulation, which in turn influences the type and dosage of medications prescribed.
For women with low AMH, clinicians may opt for more aggressive stimulation protocols or consider alternative approaches such as natural or mild-stimulation IVF cycles. For women with high AMH — particularly those with PCOS — lower doses of gonadotrophins and careful monitoring help reduce the risk of OHSS whilst still aiming for an optimal number of eggs.
AMH is also increasingly used in fertility preservation counselling. Women who are considering delaying parenthood for personal or professional reasons may use their AMH result alongside their age to make more informed decisions about whether and when to freeze eggs. It is worth emphasising that whilst a reassuring AMH level can provide some comfort, it does not guarantee future fertility, as egg quality continues to decline with age regardless of reserve.
In addition, AMH testing is sometimes used to monitor ovarian function after cancer treatment, surgery on the ovaries, or in the assessment of conditions like endometriosis that may affect ovarian reserve.
There is no single right time to have an AMH test, but there are several situations where it can provide genuinely useful information:
It is increasingly common for women in their late twenties and thirties to request AMH testing as part of a proactive approach to their health. Whilst the test is not a crystal ball, it can empower you to make decisions with more information rather than less. If you are considering having your hormones assessed, a gynaecological consultation can help place your results in the proper clinical context.
Whilst AMH is relatively stable compared to other reproductive hormones, certain factors can influence your result. Age is the most significant — AMH levels peak in the early to mid-twenties and gradually decline thereafter, eventually becoming undetectable after menopause.
Hormonal contraceptives, particularly the combined oral contraceptive pill, can suppress AMH levels somewhat. If you have your AMH tested whilst taking hormonal contraception, your result may be slightly lower than your true baseline. Some clinicians recommend retesting after a washout period if the initial result seems unexpectedly low.
Vitamin D deficiency has also been linked to lower AMH levels in some studies, although the clinical significance of this association is still being explored. Smoking is another factor that can accelerate the decline of ovarian reserve and may be reflected in a lower AMH.
Body mass index (BMI) may also play a role. Some research suggests that AMH levels can be slightly lower in women with a higher BMI, though the relationship is complex and not fully understood. Ethnicity can also affect AMH levels, with some studies reporting variations in average levels between different ethnic groups.
There is currently no proven way to increase AMH levels naturally. AMH reflects the number of remaining follicles in your ovaries, which is largely determined by genetics and age. Whilst maintaining a healthy lifestyle — including not smoking, managing stress, and eating a balanced diet — supports overall reproductive health, these measures do not raise AMH levels. Be cautious of supplements or treatments that claim to "boost" AMH, as these are not supported by robust clinical evidence.
No. A low AMH indicates a reduced number of remaining eggs, but it does not predict your ability to conceive naturally. Research has shown that women with low AMH but no other fertility issues can have similar natural conception rates to women with normal AMH levels. However, low AMH may mean fewer eggs are available during IVF, which can affect treatment success rates. It is always best to discuss your individual result with a healthcare professional who can consider the full picture.
There is no universally recommended age for AMH testing. However, if you are in your late twenties or thirties and plan to delay pregnancy, testing can provide useful baseline information. Women with risk factors such as a family history of early menopause, previous ovarian surgery, or autoimmune conditions may benefit from earlier testing. Ultimately, the best time to test is whenever you want more information to support your reproductive planning.
AMH can provide some indication of where you sit on the spectrum of ovarian ageing. Very low AMH levels in younger women may suggest that menopause could arrive earlier than average. However, AMH alone cannot accurately predict the exact timing of menopause. It is one piece of the puzzle, alongside family history, cycle regularity, and other hormonal markers.
AMH testing is typically available on the NHS when it is part of a fertility investigation or IVF treatment pathway. It is not routinely offered as a screening test for women who are not experiencing fertility difficulties. If you would like an AMH test outside of these criteria, private clinics offer it as a straightforward and affordable blood test, often with results available within a few working days.
The information provided in this article is for educational purposes only and is based on NHS recommendations. It is not a substitute for professional medical advice. Always consult your doctor or a qualified healthcare provider for advice on medical conditions or treatments.
Our medical centre is at 36 Spital Square, E1 6DY, City of London.
